Prevalence and biomarkers of pre-cachexia and cachexia in advanced cancer patients scheduled for treatment with chemotherapy

Prevalence and biomarkers of pre-cachexia and cachexia in advanced cancer patients scheduled for treatment with chemotherapy - (Pre-)cachexia in cancer patients undergoing chemotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35709

Enrollment

Registered

2011-10-06

Start date

2011-10-06

Completion date

Unknown

Last updated

2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer Neoplasms

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Adults (> 18 years); - Stage III/IV non small cell lung cancer - Treatment plan: palliative chemotherapy or chemoradiation

Exclusion criteria

Exclusion criteria: -Ascites (for which treatment is necessary) or serious pitting edema; -Chemotherapy treatment in the past month; -Not able to speak the Dutch language; -Pregnancy.

Design outcomes

Primary

Measure	Time frame
Prevalence of pre-cachexia and cachexia.	—

Secondary

Measure	Time frame
-The prevalence of pre-cachexia related to tumour type -Potential biomarkers of pre-cachexia will be investigated	—

Countries

Netherlands

Outcome results